Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Cassava Sciences Inc

Drug Company's Libel Lawsuit Against Scientists Dismissed

From yesterday's decision by Judge Gregory Woods (S.D.N.Y.) in Cassava Sciences, Inc. v. Bredt: Cassava Sciences, Inc. ("Cassava") is a biotechnology company that is conducting clinical trials for an Alzheimer's drug called simufilam. Following the second phase of the simufilam clinical trials, multiple short sellers, most of them scientists, published…

Reason

2 Stocks You Should Think About Shorting

Interest rate increases and consequent market volatility look all set to persist in light of the better-than-expected September employment figures. Since the outlook seems bleak for fundamentally weak stocks SoFi Technologies (SOFI) and Cassava Sciences (SAVA), one may consider selling them short. Continue reading….

StockNews.com

5 Stocks to Delete From Your Watchlist in Q4

The stock market has been experiencing wild swings this year, with inflation at a multi-decade high and the Fed aggressively raising interest rates to bring it under control. Amid rising recession worries, we think fundamentally weak stocks, Advanced Micro Devices (AMD), Block (SQ), Ginkgo Bioworks (DNA), Rocket Lab USA (RKLB),…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

Over $2 Million Bet On Cassava Sciences; 4 Stocks Insiders Are Buying

Although US stocks closed mixed on Tuesday, there were a few notable insider trades.

Benzinga

New York Times Report Fresh Allegations On Cassava's Simufilam Alzheimer's Trials, Shares Fall

Cassava Sciences Inc (NASDAQ: SAVA) shares are shedding over 20% after

Benzinga

How Is The Market Feeling About Cassava Sciences Inc?

Cassava Sciences Inc's (NASDAQ:SAVA) short percent of float has fallen 3.25% since its last report. The company recently reported that it has 10.93 million shares sold short, which is 30.09% of all regular shares that are available for trading.

Benzinga

People

Santanu RoyHaving

215 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Advanced Micro Devices, Inc

60 stories

SoFi Technologies Inc

Ginkgo Bioworks Holdings Inc

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.